MET and renal carcinoma: We have found that SEMA3C stimulates EGFR and MET signaling in a broad range of cancer cell lines including bladder, and renal cancer as well as glioblastoma, suggesting that SEMA3C may be an important growth factor for a broad spectrum of cancers in addition to PCa.